Sleep Medicine Reviews
Volume 6, Issue 4 , Pages 253-265, July 2002

Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder

  • Karin Stiasny

      Affiliations

    • Department of Neurology, Center of Nervous Diseases, Philipps University of Marburg, Germany
  • ,
  • Wolfgang Hermann Oertel

      Affiliations

    • Department of Neurology, Center of Nervous Diseases, Philipps University of Marburg, Germany
  • ,
  • Claudia Trenkwalder

      Affiliations

    • Department of Clinical Neurophysiology, University of Göttingen, Germany

Abstract 

Patients with restless legs syndrome (RLS) suffer from sensory and motor symptoms evoked in the limbs at rest. Symptoms increase in the evening and during the night. The circadian rhythm and the presence of involuntary periodic limb movement in sleep (PLMS) which are frequently associated with arousals probably cause the leading symptom of sleep disturbances in RLS. Patients who do not have typical RLS symptoms but whose polysomnography shows PLMS that either impact on sleep continuity or daytime functioning are diagnosed as having the periodic limb movement disorder (PLMD). Dopaminergic agents such as levodopa/dopa decarboxylase inhibitor (DDI) and dopamine agonists are considered the treatment of choice for RLS and PLMS. This article gives an overview of the epidemiology, pathophysiology, clinical symptomatology and diagnosis of RLS and PLMD and focuses on treatment strategies in both disorders.

Keywords: restless legs syndrome (RLS), periodic limb movement disorder (PLMD), periodic limb movements (PLM), periodic limb movements in sleep (PLMS), therapy, levodopa, dopamine agonist

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence should be addressed to: K. Stiasny, Department of Neurology, Center of Nervous Diseases, Rudolf-Bultmann-Strasse 8, D-35033 Marburg, Germany. Fax: 0049-6421-28-65307; E-mail:stiasny@mailer.uni-marburg.de

PII: S1087-0792(01)90193-5

doi:10.1053/smrv.2001.0193

Sleep Medicine Reviews
Volume 6, Issue 4 , Pages 253-265, July 2002